NCT01914770: Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76 |
|
|
| Completed | N/A | 1016 | US | Belimumab 1 mg/kg, Belimumab 10 mg/kg, Placebo | GlaxoSmithKline, Human Genome Sciences Inc. | Systemic Lupus Erythematosus | 11/10 | 11/10 | | |
NCT01033500: Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients |
|
|
| Withdrawn | N/A | 0 | US | Belatacept | University of Wisconsin, Madison, Bristol-Myers Squibb | Islets of Langerhans Transplantation, Diabetes Mellitus, Type 1, Kidney Transplantation | 12/12 | 12/12 | | |
